APRIL GARDNER: Open Payments
NPI 1780885970 · LEES SUMMIT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,486 in 75 payments from 15 companies in 2025. Trend: 2023 $1,914 · 2024 $1,647 · 2025 $1,486
Food & beverage: $1,486
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $230 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $189 |
| Lundbeck LLC | 6 | $157 |
| E.R. Squibb & Sons, L.L.C. | 8 | $147 |
| Vanda Pharmaceuticals Inc. | 6 | $133 |
| Otsuka America Pharmaceutical, Inc. | 6 | $115 |
| Alkermes, Inc. | 4 | $98 |
| Axsome Therapeutics, Inc. | 4 | $84 |
| Teva Pharmaceuticals USA, Inc. | 4 | $76 |
| Supernus Pharmaceuticals, Inc. | 3 | $75 |
Products named: VRAYLAR, REXULTI, CAPLYTA, COBENFY, ARISTADA, Auvelity, ABILIFY ASIMTUFII, FANAPT.
Industry payments across MO — which companies pay providers there.
